Syneos Health Inc (SYNH) is around the top of the Diagnostics & Research industry according to InvestorsObserver. SYNH received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Syneos Health Inc also achieved a score of 91 in the Diagnostics & Research industry, putting it above 91 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 76 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Syneos Health Inc Stock Today?
Syneos Health Inc (SYNH) stock is trading at $82.24 as of 9:46 AM on Thursday, Apr 15, a gain of $2.70, or 3.39% from the previous closing price of $79.54. The stock has traded between $80.54 and $82.66 so far today. Volume today is below average. So far 11,153 shares have traded compared to average volume of 979,331 shares.